http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07277964-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1994-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9c0415522537e95e0f29ffd61511a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a9fc2de93c6bdf85872e3f905f93abc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f5deaa8c0d10a98af189f4021eb5ca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d89361ae0d6f33117e63d4855d549bdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad7f8bf26fd05995ca9cf0b339ebca48
publicationDate 1995-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H07277964-A
titleOfInvention Antitumor agent
abstract (57) [Summary] [Object] To provide an antitumor agent having an antitumor effect against colorectal cancer, non-small cell lung cancer, gastric cancer, melanoma and other refractory cancers. [Structure] The present invention is represented by the following formula: 3,7,11,15,19-pent An anti-tumor agent containing a-azaheneicosane (BE3333) or its salt as an active ingredient, which suppresses the growth of colon cancer, non-small cell lung cancer, gastric cancer, melanoma and other refractory cancers by intravenous or intraperitoneal administration. Show the effect. [Chemical 1]
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6982351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011084586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7491849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7253207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0066587-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6794545-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7453011-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6649587-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4743673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002543202-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19649761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19649761-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6809176-B2
priorityDate 1994-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCCAG33189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9948321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6993689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415709125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453095146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1103
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421873803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4418048
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234666633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524130

Total number of triples: 49.